Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 3,797 | 62,957 | 49,410 | 374,557 | -40,629 |
| Cost of Goods | 22 | 1,907 | 5,996 | 22,253 | 27,921 |
| Gross Profit | 3,775 | 61,050 | 43,414 | 352,304 | -68,550 |
| Operating Expenses | 218,983 | 205,328 | 194,912 | 157,593 | 157,593 |
| Operating Income | -215,186 | -143,371 | -150,502 | 194,964 | -225,222 |
| Other Income | 17,563 | 183 | -1,136 | 22,768 | -8,499 |
| Pre-tax Income | -197,623 | -143,188 | -151,638 | 217,732 | -233,721 |
| Income Tax | -2,848 | -2,232 | -50,035 | 42,420 | -157,228 |
| Net Income Continuous | -194,775 | -140,956 | -101,603 | 175,312 | -76,493 |
| Minority Interests | N/A | -56 | N/A | N/A | N/A |
| Net Income | $-194,775 | $-140,900 | $-101,603 | $175,312 | $-76,493 |
| EPS Basic Total Ops | -1.45 | -1.06 | -0.78 | 1.32 | -0.58 |
| EPS Basic Continuous Ops | -1.45 | -1.06 | -0.78 | 1.32 | -0.58 |
| EPS Diluted Total Ops | -1.45 | -1.06 | -0.74 | 1.30 | -0.58 |
| EPS Diluted Continuous Ops | -1.45 | -1.06 | -0.75 | 1.30 | -0.58 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -1.06 | -0.76 | N/A | N/A |
| EBITDA(a) | $-213,439 | $-147,098 | $-156,177 | $193,599 | $-222,967 |